Remifentanil is a medicine used to make people sleepy during surgery or childbirth. It's a type of painkiller that works quickly and wears off fast. Doctors use it in hospitals.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Remifentanil, sold as Ultiva and as a generic, is a powerful, very short-acting opioid pain medicine used only in hospitals and surgery centers. Anesthesia clinicians give it through a vein to block pain during surgery and other procedures. In the US it is approved as the pain-relief part of general anesthesia. It is also approved for pain relief that continues into the first period after surgery in adults who stay under an anesthesia clinician's direct care in a recovery or intensive care unit. And it can be part of monitored anesthesia care in adults, a lighter sedation in which the person keeps breathing on their own. It is not a medicine anyone takes at home. Its main appeal is control: the team can deepen or lighten its effect within minutes as the needs of the procedure change. Some hospitals also use it outside these approved uses. During labor, a pump that lets the woman give herself small doses (patient-controlled analgesia, or PCA) is sometimes offered when an epidural is not possible or not wanted. Limited studies suggest it relieves labor pain better than other opioid injections but less well than an epidural, and it can slow the mother's breathing, so breathing and oxygen levels need close watching. It also crosses the placenta, so the newborn is checked for drowsiness or slow breathing. The US label does not recommend remifentanil during or just before labor. Some intensive care units also use it to keep people on a breathing machine comfortable; small studies suggest this may shorten time on the machine, but the evidence is limited.
Remifentanil attaches to the opioid receptors that morphine and fentanyl also act on, in the brain and spinal cord. This dampens pain signals. It also slows breathing and can lower heart rate and blood pressure, which is why it is given only with continuous monitoring. What sets it apart is how quickly it is cleared. Most opioids are broken down by the liver, but remifentanil is broken down within minutes by enzymes called esterases that are found throughout the blood and tissues. It starts working about a minute after it reaches the bloodstream, and its effects fade within 5 to 10 minutes of stopping, whether the infusion ran for twenty minutes or several hours. Even severe liver disease does not change how it is handled, so its action is predictable. The flip side is that pain relief also disappears quickly, so the team gives longer-acting pain medicine before it is stopped.
Remifentanil comes as a powder that is dissolved and given into a vein, almost always as a continuous infusion through a pump, sometimes with small extra doses during general anesthesia. The anesthesia team sets and adjusts the rate based on body weight, the procedure, the other anesthetic drugs in use and how the person responds. Starting doses are usually cut in half for people over 65. It is not used on its own to put someone to sleep, because it does not reliably cause unconsciousness. It is paired with an anesthetic such as propofol or an inhaled gas, and it allows the team to use less of those drugs. It is given only where breathing, oxygen level, heart rate and blood pressure are watched continuously by people trained in airway care, with oxygen, breathing equipment and the opioid-reversal medicine naloxone at hand. When the infusion ends, the IV line is flushed so that no leftover drug is pushed in later with other fluids.
During anesthesia, the effects that matter most are ones the team watches for and treats: slowed or paused breathing, a slow heart rate, low blood pressure and muscle stiffness. In someone breathing on their own during sedation, the team may lower the dose or briefly pause it if breathing slows. Stiffness of the chest muscles, which can make breathing or ventilation difficult, is linked to larger or faster doses and is treated by slowing the infusion or giving a muscle relaxant. After waking, nausea, vomiting, shivering, itching and headache are among the more common complaints. Because remifentanil wears off so quickly, some people feel more pain on waking than they expect. Opioids can also occasionally make the body more sensitive to pain, a problem called opioid-induced hyperalgesia. Telling the recovery team about pain early lets them adjust the plan.
Remifentanil carries a boxed warning, the most prominent kind of warning the US Food and Drug Administration requires, for three opioid risks. Breathing can slow dangerously, especially when it is started or the dose goes up. Combining it with benzodiazepines (sedatives such as midazolam) or other drugs that slow the brain, including other opioids, sleep medicines, muscle relaxants, gabapentin and pregabalin (nerve pain and seizure medicines such as Neurontin and Lyrica) and alcohol, can cause profound sedation and suppress breathing. And it is a federally controlled opioid that carries risks of addiction and misuse, which is why hospitals keep it under strict control. During anesthesia, several of these drugs are often given together on purpose, which is why the team lowers doses and monitors closely. Tell the anesthesia team about every medicine and supplement you take. This matters most for regular opioid use; buprenorphine or other partial opioid medicines, which can blunt remifentanil's pain relief or trigger withdrawal; and antidepressants, migraine medicines or other drugs that raise serotonin, since together they can rarely cause serotonin syndrome (agitation, fever, a fast heartbeat and twitching or stiff muscles). Also mention lung disease that limits breathing, a seizure disorder or a recent head injury, which call for extra care. Remifentanil should not be used in anyone who has had an allergic reaction to it.
Most people never notice remifentanil itself; it runs in the background while they are asleep or sedated. Because it clears within minutes, its effects are gone soon after the infusion stops, although other drugs given alongside it may leave a person drowsy for longer. Pain control is handed over to longer-acting medicines before or as you wake. If pain builds quickly in the recovery area, tell the nurse; this is an expected result of the drug's short action, and the team can add more pain relief. There is no ongoing course of treatment and no prescription to fill. After an outpatient procedure, follow the discharge instructions about alcohol, driving and other sedating medicines, usually for at least 24 hours, since those cautions cover the whole anesthetic, not remifentanil alone. If you are breastfeeding, ask the team about timing, since the label advises watching a breastfed infant for unusual sleepiness or slow breathing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Remifentanil, what you've noticed, or ask the community a question.